A detailed history of Hollencrest Capital Management transactions in Haleon PLC stock. As of the latest transaction made, Hollencrest Capital Management holds 5,428 shares of HLN stock, worth $51,457. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5,428
Previous 4,873 11.39%
Holding current value
$51,457
Previous $40,000 42.5%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

BUY
$8.32 - $10.7 $4,617 - $5,938
555 Added 11.39%
5,428 $57,000
Q2 2024

Aug 12, 2024

SELL
$8.01 - $8.64 $30,582 - $32,987
-3,818 Reduced 43.93%
4,873 $40,000
Q3 2023

Nov 13, 2023

BUY
$7.85 - $8.94 $4,270 - $4,863
544 Added 6.68%
8,691 $72,000
Q2 2023

Aug 10, 2023

BUY
$8.04 - $9.0 $8,305 - $9,297
1,033 Added 14.52%
8,147 $68,000
Q1 2023

May 16, 2023

BUY
$7.57 - $8.37 $9,523 - $10,529
1,258 Added 21.48%
7,114 $57,000
Q4 2022

Feb 06, 2023

BUY
$5.96 - $8.06 $34,901 - $47,199
5,856 New
5,856 $46,000

Others Institutions Holding HLN

About Haleon plc


  • Ticker HLN
  • Exchange
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 4,617,290,240
  • Market Cap $43.8B
  • Description
  • Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, mineral...
More about HLN
Track This Portfolio

Track Hollencrest Capital Management Portfolio

Follow Hollencrest Capital Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hollencrest Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Hollencrest Capital Management with notifications on news.